ATLAS fair value
₹638.91
Above fair value · 190% premium
Dr. Lal PathLabs share price today, ATLAS forecast and fair value
Healthcare · Diagnostics & Research · National Stock Exchange of India · India
Prices as of Oct 26, 2026 · INR
₹638.91
Above fair value · 190% premium
53%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Dr. Lal PathLabs's fair value at about ₹638.91 per share (reasonable range: ₹383.87 to ₹1,063). At ₹1,856, the stock trades 190% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Dr. Lal PathLabs a 53% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹1,792 and ₹1,936; in 9 out of 10, between ₹1,673 and ₹2,074. Estimated annual volatility is 20%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Dr. Lal PathLabs sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks LALPATHLAB.NSE has traded between ₹1,273 and ₹2,039. Today it is 9.0% below that high and 46% above its low.
On the business: net margin is 18.8%; it trades at 56.8 times earnings.
Its beta is 0.16: it tends to move less than the market.
Dr.
Want to see everything about Dr. Lal PathLabs?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About ₹638.91 per share according to ATLAS (reasonable range: ₹383.87 to ₹1,063). With the stock at ₹1,856, it is 190% above it.
53%: close to a coin flip. In half of the simulated outcomes, LALPATHLAB.NSE ends the month between ₹1,792 and ₹1,936.
Dr. Lal PathLabs's market capitalization is ₹308B. Its price-to-earnings (P/E) ratio is 56.8: you pay ₹56.8 for each ₹1.00 of yearly earnings.
Yes. LALPATHLAB.NSE's current dividend yield is 1.10% at today's price (₹1,856).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy